Blog - Page 1168 of 5716

ThursdayNov 04, 2021 1:44 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE) Releases Update on Post-Merger Share Count

Net Element (NASDAQ: NETE), a global technology and value-added solutions group, and Mullen Automotive Inc., an emerging electric vehicle (“EV”) manufacturer, has shared updated information regarding a previously announced definitive stock-for-stock reverse merger agreement between the two companies. In the announcement, Mullen noted that the number of fully diluted shares upon completion of the merger will be 32% less than the 75 million shares outlined in the agreement. Following the merger, the number of outstanding shares will be 51,173,640 million in total. “We are excited about the many milestones ahead of us and look forward to sharing those with all our…

ThursdayNov 04, 2021 1:22 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), Provides Studies, Clinical Trials Update

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has released an update on strategic initiatives related to its MINDCURE Research and MINDCURE Technology divisions. According to the company, its synthetic ibogaine efforts, which were announced in March 2021, include the application for two patents and the initiation of production of Good Laboratory Practice (“GLP”) ibogaine leading to the production of Good Manufacturing Practice (“GMP”) ibogaine. The company is on schedule to provide GLP supply to research partners by Q2 2022. The company is in the process of preparing to ship…

ThursdayNov 04, 2021 1:00 pm

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) Experiencing Massive Growth Ahead of American Gaming Association’s Bullish 2022 Prediction

American Gaming Association’s Gaming CEO Outlook expects industry growth in 2020 driven by new hiring, wage growth, and capital investment PLGNF sees explosive growth in October 2021 with a 1500% betting handle increase, and betting turnover reached approximately $1.6 million per day from $53,500 for September PLGNF’s IP-protected iGaming software solutions include Live Dealer Casino, E-Table Games, Daily Fantasy Sports PLGNF applications run securely on any browser without app store download, do not require sharing sensitive data Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF), a SaaS technology company focused on developing and licensing digital content for the growing global iGaming market,…

ThursdayNov 04, 2021 12:47 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Marks Another Significant Milestone with IND Application for Fibromyalgia Phase 2a Clinical Trial

Tryp just filed an IND with the FDA for its TRP-8802 clinical candidate for its Phase 2a clinical trial The trial is set to commence in 2022, subject to a favorable review by the FDA The study will be conducted in collaboration with the University of Michigan and will aim at evaluating the safety and clinical utility of psilocybin for fibromyalgia Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) just announced its submission of an Investigational New Drug (“IND”) application to the United States Food and Drug Administration (“FDA”) for its TRP-88802 clinical candidate. This application follows the commencement of Tryp’s Phase…

ThursdayNov 04, 2021 12:28 pm

QualityStocksNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Diabetes Technology Society Conference

Nemaura Medical (NASDAQ: NMRD) CEO Faz Chowdhury, PhD, will be presenting at annual meeting of the Diabetes Technology Society. The two-day meeting is slated for Nov. 5–6, 2021, with virtual workshops on Thursday, Nov. 4; Chowdury’s presentation is scheduled for Nov. 4, at 2 p.m. ET. The aim of the Diabetes Technology Society meeting is to connect technology developers with users in order to encourage and support the development of new tools to help people with diabetes. The meeting will also feature an update on current U.S. regulatory policies, presented by FDA officials. The format of the meeting is designed to…

ThursdayNov 04, 2021 12:12 pm

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Growth Strategy Moves Forward with Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF) Partnership for Ketamine-Assisted Psychotherapy Distribution

The distribution component unlocks a new revenue source for the company, helping drive future growth MINDCURE’s platform was built as a digital tool and distribution platform, and has already been used for deployment and distribution of ketamine for depression and pain Digital therapeutics market is projected to reach USD $13.1 billion by 2026 from USD $3.4 billion in 2021 at a CAGR of 31.4 %, a substantial increase primarily driven by the COVID-19 pandemic and the stressors associated with it MINDCURE’s target areas and value proposition list numerous benefits for therapists, patients, payers, and drug and protocol developers, through the…

ThursdayNov 04, 2021 11:26 am

QualityStocksNewsBreaks – Tingo Inc. (IWBB), MELD Partnership Bringing Financial Freedom, Individualized Control to Masses

Tingo (OTCQB: IWBB) recently announced a partnership with MELD, a DeFi non-custodial banking protocol for secure lending and borrowing of crypto and fiat currencies, in a bid to bring the protocol to customers in Africa. “Working within the framework of the United Nations’ SDGs and Environmental, Social and Corporate Governance (‘ESG’) impact investing, Tingo aims to be part of the solution for the African continent in several key areas — including food security — through the promotion of female entrepreneurship, financial inclusion, poverty alleviation and zero hunger,” reads a recent article. “With this unique partnership, Tingo hopes to make its…

ThursdayNov 04, 2021 11:10 am

QualityStocksNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) Helping Clients Increase Revenue, Reduce Costs, Enhance Customer Service

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, empowers clients with business-driven solutions that help increase revenue, reduce costs and enhance customer service quality and satisfaction. With over ten years of experience providing customer engagement and SaaS for large enterprises in the finance industry, IFBD has a comprehensive customer engagement SaaS solutions portfolio that is highly intelligent, customizable, provides proof of stability and security at scale, and includes a concurrence of over 10,000 agents. Recently, the company extended its dedication and commitment to improving its offering by successfully expanding into the consumer and retail product providers market.…

ThursdayNov 04, 2021 10:55 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives Schedule I Manufacturing License from DEA

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics(TM), has been granted a Schedule I manufacturing license from the U.S. Drug Enforcement Agency (“DEA”). Granted for Cybin’s research lab located in the Boston area, the license is required for investigators who plan to study, produce, analyze or otherwise work with Schedule I controlled substances. According to the announcement, the company is working to become a hub for innovation and drug discovery. Cybin has relied on in-house capabilities as well as globally licensed research organizations in the United States, Canada and the United Kingdom for most…

ThursdayNov 04, 2021 10:45 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Participate in Panel Discussion at Wonderland: Miami

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that it will participate in Wonderland: Miami, presented by Microdose. The event is set to take place Nov. 8-9, 2021, in Miami, Florida. Tryp’s chairman and CEO Greg McKee will participate in a panel discussion entitled, “Developing Psychedelic Medicine Beyond What We Already Know,” beginning at 2:40 p.m. ET on Nov. 8. In the discussion, McKee will highlight Tryp's leading-edge work with synthetic psilocybin for chronic pain and other indications. To view the full press release, visit https://ibn.fm/VSiM7…

Site Search

Company Search